Avanos Medical, Inc. (AVNS) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
AVNS Revenue Growth
Revenue Breakdown (FY 2025)
AVNS's revenue distribution by segment and geography for fiscal year 2025
By Product/Segment
By Geography
AVNS Revenue Analysis (2014–2025)
As of May 8, 2026, Avanos Medical, Inc. (AVNS) generated trailing twelve-month (TTM) revenue of $715.9 million, reflecting solid growth of +8.8% year-over-year. The most recent quarter (Q1 2026) recorded $182.2 million in revenue, up 0.7% sequentially.
Looking at the longer-term picture, AVNS's 5-year compound annual growth rate (CAGR) stands at -0.4%, indicating revenue contraction over this period. The company achieved its highest annual revenue of $1.67 billion in 2014.
Revenue diversification analysis shows AVNS's business is primarily driven by Corporate Other (100%). With over half of revenue concentrated in Corporate Other, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including MMSI (+11.2% YoY), NVCR (+8.5% YoY), and ITGR (+6.0% YoY), AVNS has underperformed the peer group in terms of revenue growth. Compare AVNS vs MMSI →
AVNS Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| AVNSCurrent | $716M | +8.8% | -0.4% | -8.8% | |
 MMSI | $1.5B | +11.2% | +9.5% | 12.2% | |
 NVCR | $655M | +8.5% | +5.8% | -23.5% | |
 ITGR | $1.8B | +6.0% | +11.5% | 11.3% | |
 ATRC | $535M | +15.0% | +20.9% | -0.6% | |
 NTRA | $2.3B | +35.9% | +42.6% | -13.4% |
AVNS Historical Revenue Data (2014–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $701.2M | +1.9% | $349.0M | 49.8% | $-61,600,000 | -8.8% |
| 2024 | $687.8M | +2.2% | $381.3M | 55.4% | $40.0M | 5.8% |
| 2023 | $673.3M | -1.6% | $379.7M | 56.4% | $65.0M | 9.7% |
| 2022 | $684.1M | -8.1% | $394.2M | 57.6% | $41.9M | 6.1% |
| 2021 | $744.6M | +4.2% | $379.9M | 51.0% | $86.8M | 11.7% |
| 2020 | $714.8M | +2.5% | $390.6M | 54.6% | $70.9M | 9.9% |
| 2019 | $697.6M | +6.9% | $402.2M | 57.7% | $-5,400,000 | -0.8% |
| 2018 | $652.3M | +6.7% | $390.9M | 59.9% | $34.9M | 5.4% |
| 2017 | $611.6M | +8.0% | $336.9M | 55.1% | $-16,000,000 | -2.6% |
| 2016 | $566.2M | -64.0% | $297.2M | 52.5% | $-69,400,000 | -12.3% |
See AVNS's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs AVNS Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare AVNS vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonAVNS — Frequently Asked Questions
Quick answers to the most common questions about buying AVNS stock.
Is AVNS's revenue growth accelerating or slowing?
AVNS maintains +8.8% revenue growth, in line with its 5-year CAGR of -0.4%. TTM revenue stands at $716M. Growth rate remains consistent with historical average.
What is AVNS's long-term revenue growth rate?
Avanos Medical, Inc.'s 5-year revenue CAGR of -0.4% reflects the sustained expansion pattern. Current YoY growth of +8.8% is near this long-term average.
How is AVNS's revenue distributed by segment?
AVNS reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.